Rosamund Chapman

914 total citations
40 papers, 642 citations indexed

About

Rosamund Chapman is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Rosamund Chapman has authored 40 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Virology, 18 papers in Immunology and 12 papers in Epidemiology. Recurrent topics in Rosamund Chapman's work include HIV Research and Treatment (17 papers), Transgenic Plants and Applications (10 papers) and Herpesvirus Infections and Treatments (9 papers). Rosamund Chapman is often cited by papers focused on HIV Research and Treatment (17 papers), Transgenic Plants and Applications (10 papers) and Herpesvirus Infections and Treatments (9 papers). Rosamund Chapman collaborates with scholars based in South Africa, United Kingdom and United States. Rosamund Chapman's co-authors include Anna‐Lise Williamson, Edward P. Rybicki, Emmanuel Margolin, Ann E. Meyers, Nicola Douglass, Michiel T. van Diepen, Enid Shephard, Gerald K. Chege, Penny L. Moore and Miles B. Brennan and has published in prestigious journals such as Gastroenterology, PLoS ONE and Nature Reviews Microbiology.

In The Last Decade

Rosamund Chapman

40 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosamund Chapman South Africa 16 280 267 241 187 150 40 642
David Hallengärd Sweden 16 200 0.7× 187 0.7× 100 0.4× 434 2.3× 172 1.1× 27 772
Daniel Chargelegue United Kingdom 16 286 1.0× 558 2.1× 496 2.1× 127 0.7× 85 0.6× 20 914
Lesley McLain United Kingdom 16 198 0.7× 198 0.7× 206 0.9× 225 1.2× 253 1.7× 24 761
Darren B. Leneghan United Kingdom 7 120 0.4× 309 1.2× 80 0.3× 91 0.5× 53 0.4× 10 529
Shakuntala Megati United States 11 331 1.2× 150 0.6× 79 0.3× 172 0.9× 191 1.3× 11 582
Maria Cândida M. Mellado Portugal 9 169 0.6× 310 1.2× 95 0.4× 297 1.6× 43 0.3× 10 783
Jorge Reyes‐del Valle United States 12 105 0.4× 156 0.6× 47 0.2× 399 2.1× 73 0.5× 15 721
Marilène Bolduc Canada 14 123 0.4× 229 0.9× 205 0.9× 109 0.6× 20 0.1× 22 587
Barry Ellefsen United States 14 140 0.5× 132 0.5× 100 0.4× 203 1.1× 42 0.3× 16 479
Patrick Sanz United States 13 80 0.3× 438 1.6× 83 0.3× 131 0.7× 122 0.8× 19 627

Countries citing papers authored by Rosamund Chapman

Since Specialization
Citations

This map shows the geographic impact of Rosamund Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosamund Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosamund Chapman more than expected).

Fields of papers citing papers by Rosamund Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosamund Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosamund Chapman. The network helps show where Rosamund Chapman may publish in the future.

Co-authorship network of co-authors of Rosamund Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Rosamund Chapman. A scholar is included among the top collaborators of Rosamund Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosamund Chapman. Rosamund Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lemmer, Yolandy, Rosamund Chapman, Célia Abolnik, et al.. (2024). Protective efficacy of a plant-produced beta variant rSARS-CoV-2 VLP vaccine in golden Syrian hamsters. Vaccine. 42(4). 738–744. 2 indexed citations
2.
3.
Chapman, Rosamund, et al.. (2023). Improved DNA Vaccine Delivery with Needle-Free Injection Systems. Vaccines. 11(2). 280–280. 56 indexed citations
4.
Chapman, Rosamund, Michiel T. van Diepen, Nicola Douglass, et al.. (2023). Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines. Vaccines. 11(2). 376–376. 3 indexed citations
5.
Chapman, Rosamund, Nicola Douglass, Mohamed Jaffer, et al.. (2023). Development of a dual vaccine against East Coast fever and lumpy skin disease. Frontiers in Immunology. 14. 1143034–1143034. 4 indexed citations
6.
Chapman, Rosamund, et al.. (2023). Lumpy Skin Disease—An Emerging Cattle Disease in Europe and Asia. Vaccines. 11(3). 578–578. 32 indexed citations
7.
Chapman, Rosamund, Ann E. Meyers, Emmanuel Margolin, et al.. (2022). Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein. Nanotechnology. 33(48). 485102–485102. 6 indexed citations
8.
Margolin, Emmanuel, Rosamund Chapman, Ann E. Meyers, et al.. (2022). Investigating Constraints Along the Plant Secretory Pathway to Improve Production of a SARS-CoV-2 Spike Vaccine Candidate. Frontiers in Plant Science. 12. 798822–798822. 12 indexed citations
9.
Margolin, Emmanuel, Yulia Meshcheriakova, Hadrien Peyret, et al.. (2020). Co‐expression of human calreticulin significantly improves the production of HIV gp140 and other viral glycoproteins in plants. Plant Biotechnology Journal. 18(10). 2109–2117. 49 indexed citations
10.
Chapman, Rosamund, Ann E. Meyers, Emmanuel Margolin, et al.. (2020). Characterization and Immunogenicity of HIV Envelope gp140 Zera® Tagged Antigens. Frontiers in Bioengineering and Biotechnology. 8. 321–321. 5 indexed citations
11.
Margolin, Emmanuel, Richard Strasser, Rosamund Chapman, et al.. (2020). Engineering the Plant Secretory Pathway for the Production of Next-Generation Pharmaceuticals. Trends in biotechnology. 38(9). 1034–1044. 39 indexed citations
12.
Diepen, Michiel T. van, Rosamund Chapman, Nicola Douglass, et al.. (2019). Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus. Journal of Virology. 93(8). 29 indexed citations
13.
Diepen, Michiel T. van, Rosamund Chapman, Penny L. Moore, et al.. (2018). The adjuvant AlhydroGel elicits higher antibody titres than AddaVax when combined with HIV-1 subtype C gp140 from CAP256. PLoS ONE. 13(12). e0208310–e0208310. 16 indexed citations
14.
15.
Chapman, Rosamund, et al.. (2016). HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice. PLoS ONE. 11(7). e0159141–e0159141. 13 indexed citations
16.
17.
Chapman, Rosamund, et al.. (2010). Recombinant Mycobacterium bovis BCG as an HIV Vaccine Vector. Current HIV Research. 8(4). 282–298. 36 indexed citations
18.
Williamson, Anna‐Lise, et al.. (2009). Optimisation of a mycobacterial replicon increases foreign antigen expression in mycobacteria. Tuberculosis. 89(3). 225–232. 4 indexed citations
19.
Healey, Christopher, et al.. (1998). Genetic variation in Immune epitopes in core and envelope regions of hepatitis C virus. UCL Discovery (University College London). 2 indexed citations
20.
Healey, Christopher, Steve McAdam, Magdalena Plebanski, Rosamund Chapman, & William Rosenberg. (1996). Cytotoxic T lymphocyte epitopes in hepatitis C virus identified with HLA assembly assays.. Gastroenterology. 110. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Hallengärd Breakdown of academic impact, for papers by Daniel Chargelegue Breakdown of academic impact, for papers by Lesley McLain Breakdown of academic impact, for papers by Darren B. Leneghan Breakdown of academic impact, for papers by Shakuntala Megati Breakdown of academic impact, for papers by Maria Cândida M. Mellado Breakdown of academic impact, for papers by Jorge Reyes‐del Valle Breakdown of academic impact, for papers by Marilène Bolduc Breakdown of academic impact, for papers by Barry Ellefsen Breakdown of academic impact, for papers by Patrick Sanz
Rankless by CCL
2026